AYTU BIOPHARMA, INC Basic Shares Outstanding (Weighted Average)
AYTU BIOPHARMA, INC (AYTU) reported Basic Shares Outstanding (Weighted Average) of 12.32 million shares for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-09-22
- AYTU BIOPHARMA, INC weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 19.30M shares, a 184.44% increase year-over-year.
- AYTU BIOPHARMA, INC weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 10.51M shares, a 71.35% increase year-over-year.
- AYTU BIOPHARMA, INC weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 10.04M shares, a 63.67% increase year-over-year.
- AYTU BIOPHARMA, INC weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 9.44M shares, a 55.59% increase year-over-year.
- AYTU BIOPHARMA, INC weighted average number of shares outstanding, basic for fiscal 2026 was 12.32M shares, a 96.17% increase from fiscal 2025.
- AYTU BIOPHARMA, INC weighted average number of shares outstanding, basic for fiscal 2025 was 6.28M shares, a 13.39% increase from fiscal 2024.
- AYTU BIOPHARMA, INC weighted average number of shares outstanding, basic for fiscal 2024 was 5.54M shares, a 65.81% increase from fiscal 2023.
- AYTU BIOPHARMA, INC weighted average number of shares outstanding, basic for fiscal 2023 was 3.34M shares, a 127.22% increase from fiscal 2022.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 19.30M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-22 | 14.90M shares derived: average of 2 quarters · filed 2026-09-22 | 13.28M shares derived: average of 3 quarters · filed 2026-09-22 | 12.32M shares 10-K · filed 2026-09-22 | ||||
| 2026-03-31 | 10.51M shares 10-Q · filed 2026-05-13 | 10.27M shares derived: average of 2 quarters · filed 2026-05-13 | 9.99M shares 10-Q · filed 2026-05-13 | 9.19M shares derived: average of 4 quarters · filed 2026-09-22 | ||||
| 2025-12-31 | 10.04M shares 10-Q · filed 2026-02-03 | 9.74M shares 10-Q · filed 2026-02-03 | 8.75M shares derived: average of 3 quarters · filed 2026-09-22 | 8.10M shares derived: average of 4 quarters · filed 2026-09-22 | ||||
| 2025-09-30 | 9.44M shares 10-Q · filed 2025-11-13 | 8.11M shares derived: average of 2 quarters · filed 2026-09-22 | 7.45M shares derived: average of 3 quarters · filed 2026-09-22 | 7.12M shares derived: average of 4 quarters · filed 2026-09-22 | ||||
| 2025-06-30 | 6.78M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-22 | 6.46M shares derived: average of 2 quarters · filed 2026-09-22 | 6.35M shares derived: average of 3 quarters · filed 2026-09-22 | 6.28M shares 10-K · filed 2026-09-22 | ||||
| 2025-03-31 | 6.13M shares 10-Q · filed 2026-05-13 | 6.13M shares derived: average of 2 quarters · filed 2026-05-13 | 6.11M shares 10-Q · filed 2026-05-13 | 5.99M shares derived: average of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | 6.13M shares 10-Q · filed 2026-02-03 | 6.10M shares 10-Q · filed 2026-02-03 | 5.94M shares derived: average of 3 quarters · filed 2026-02-03 | 5.84M shares derived: average of 4 quarters · filed 2026-02-03 | ||||
| 2024-09-30 | 6.07M shares 10-Q · filed 2025-11-13 | 5.84M shares derived: average of 2 quarters · filed 2025-11-13 | 5.74M shares derived: average of 3 quarters · filed 2025-11-13 | 5.68M shares derived: average of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | 5.62M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | 5.58M shares derived: average of 2 quarters · filed 2025-09-23 | 5.56M shares derived: average of 3 quarters · filed 2025-09-23 | 5.54M shares 10-K · filed 2025-09-23 | ||||
| 2024-03-31 | 5.53M shares 10-Q · filed 2025-05-14 | 5.53M shares derived: average of 2 quarters · filed 2025-05-14 | 5.51M shares 10-Q · filed 2025-05-14 | 5.15M shares derived: average of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | 5.52M shares 10-Q · filed 2025-02-12 | 5.50M shares 10-Q · filed 2025-02-12 | 5.02M shares derived: average of 3 quarters · filed 2025-02-12 | 4.70M shares derived: average of 4 quarters · filed 2025-02-12 | ||||
| 2023-09-30 | 5.48M shares 10-Q · filed 2024-11-13 | 4.77M shares derived: average of 2 quarters · filed 2024-11-13 | 4.42M shares derived: average of 3 quarters · filed 2024-11-13 | 4.10M shares derived: average of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | 4.06M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-26 | 3.89M shares derived: average of 2 quarters · filed 2024-09-26 | 3.63M shares derived: average of 3 quarters · filed 2024-09-26 | 3.34M shares 10-K · filed 2024-09-26 | ||||
| 2023-03-31 | 3.73M shares 10-Q · filed 2024-05-15 | 3.42M shares derived: average of 2 quarters · filed 2024-05-15 | 3.10M shares 10-Q · filed 2024-05-15 | 2.79M shares derived: average of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | 3.11M shares 10-Q · filed 2024-02-14 | 2.82M shares 10-Q · filed 2024-02-14 | 2.48M shares derived: average of 3 quarters · filed 2024-02-14 | 2.23M shares derived: average of 4 quarters · filed 2024-02-14 | ||||
| 2022-09-30 | 2.52M shares 10-Q · filed 2023-11-14 | 50.36M shares 10-Q · filed 2022-11-14 | 2.16M shares derived: average of 2 quarters · filed 2023-11-14 | 1.93M shares derived: average of 3 quarters · filed 2023-11-14 | 1.78M shares derived: average of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | 1.80M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-12 | 1.64M shares derived: average of 2 quarters · filed 2023-10-12 | 1.53M shares derived: average of 3 quarters · filed 2023-10-12 | 1.47M shares 10-K · filed 2023-10-12 | 29.40M shares 10-K · filed 2022-09-27 | |||
| 2022-03-31 | 1.48M shares 10-Q · filed 2023-05-11 | 29.69M shares 10-Q · filed 2022-05-16 | 1.40M shares derived: average of 2 quarters · filed 2023-05-11 | 1.36M shares 10-Q · filed 2023-05-11 | 27.21M shares 10-Q · filed 2022-05-16 | 6.90M shares derived: average of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | 1.32M shares 10-Q · filed 2023-02-21 | 26.41M shares 10-Q · filed 2022-02-14 | 1.30M shares 10-Q · filed 2023-02-21 | 26.00M shares 10-Q · filed 2022-02-14 | 8.71M shares derived: average of 3 quarters · filed 2023-02-21 | 11.05M shares derived: average of 4 quarters · filed 2023-02-21 | ||
| 2021-09-30 | 1.28M shares 10-Q/A · filed 2023-02-21 | 25.60M shares 10-Q · filed 2021-11-15 | 12.40M shares derived: average of 2 quarters · filed 2023-02-21 | 14.30M shares derived: average of 3 quarters · filed 2023-02-21 | 14.04M shares derived: average of 4 quarters · filed 2023-02-21 | |||
| 2021-06-30 | 23.52M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | 20.80M shares derived: average of 2 quarters · filed 2022-09-27 | 18.30M shares derived: average of 3 quarters · filed 2022-09-27 | 16.75M shares 10-K · filed 2022-09-27 | ||||
| 2021-03-31 | 18.09M shares 10-Q · filed 2022-05-16 | 15.69M shares derived: average of 2 quarters · filed 2022-05-16 | 14.49M shares 10-Q · filed 2022-05-16 | |||||
| 2020-12-31 | 13.28M shares 10-Q · filed 2022-02-14 | 12.72M shares 10-Q · filed 2022-02-14 | ||||||
| 2020-09-30 | 12.16M shares 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |